prostatic: Comparison of two treatments for prostatic cancer

In collett: Datasets from "Modelling Survival Data in Medical Research" by Collett

Comparison of two treatments for prostatic cancer

Description

Randomised controlled trial from the Veteran's Administration Cooperative Urological Research Group. Includes patients who had stage III cancers and were randomised to placebo or daily oral treatment with 1.0 mg of diethylstilbesterol (DES).

Usage

prostatic

Format

A data frame with 38 rows and 8 variables:

patient

integer patient identifier

treatment

integer treatment indicator (1=placebo; 2=daily treatment with 1.0 mg of diethylstilbesterol (DES))

time

integ er survival time from trial entry to end of follow-up in months

status

integer for follow-up status (0=alive or died from other causes, 1=died from prostate cancer

age

integer age at trial entry in years

shb

double serum hemoglobin at trial entry in g/dL

size

integer size of the primary tumour in cm^3

index

integer Gleason index based on histopathology

Details

TBC.

References

Andrews DF, Herzberg AM. Data: a collection of problems from many fields for the student and research worker. Springer Series in Statistics; Springer New York, NY; 1985. \Sexpr[results=rd]{tools:::Rd_expr_doi("10.1007/978-1-4612-5098-2")}

collett documentation built on April 3, 2025, 5:53 p.m.